ArticleCirculation2020
Substance and Substrate: LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials.
Article in Circulation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Cardiometabolic heart failure with preserved ejection fraction: from molecular signatures to personalized treatment.Cardiovascular diabetology · 2025Review
- Review
- Left ventricular ejection fraction: clinical, pathophysiological, and technical limitations.Frontiers in cardiovascular medicine · 2024Review
- SGLT2-Inhibitors on HFpEF Patients. Role of Ejection Fraction.Cardiovascular drugs and therapy · 2023Review
- Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update.Cardiovascular drugs and therapy · 2023Review
- Prognosis of Heart Failure with Mid-Range Ejection Fraction: A Story or a Version?Arquivos brasileiros de cardiologia · 2022Article
- Heart failure with preserved ejection fraction update: A review of clinical trials and new therapeutic considerations.Cardiology journal · 2022Review
- Assessing clinical and biomarker characteristics to optimize the benefits of sacubitril/valsartan in heart failure.Frontiers in cardiovascular medicine · 2022Review
- The influence of sex and body mass index on the association between soluble neprilysin and risk of heart failure hospitalizations.Scientific reports · 2021Article
- Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition.Cardiac failure review · 2020Review
Corrections and comments
- Comment on
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
32011927What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.